pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Tnkase
drug
save

tenecteplase

Marketedupdated 3mo ago
by Genentech Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • tagNephrology2 co-mentions · 1 sources
  • companyGovernment Stanley Medical College Hospital1 co-mentions · 1 sources
  • tagInfectious Disease1 co-mentions · 1 sources

all catalysts(1)

phase 3 completion · 1
Apr 28, 2026
phase 3 completion
4mo ago
Government Stanley Medical College Hospital — tenecteplase (Phase III Trial Completion)
tenecteplase
→

Trials studying tenecteplase

  • phase3A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Wellrecruitingn=1,325
  • phase3Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancyterminatedn=20
  • phase3Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Strokenot yet recruitingn=488
  • phase2Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomyrecruitingn=20
  • phase2Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Strokeenrolling by invitationn=40
  • phase1Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dosenot yet recruitingn=20
  • phase3Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENTrecruitingn=466
  • phase3Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Strokerecruitingn=398
more trials →

News(0)

no news has mentioned this drug yet

brand
Tnkase
generic
tenecteplase
indication
Acute Ischemic Stroke
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?